Recent Updates
Recently added Catalysts
SYK Positive Sentiment Score: 75/100

Stryker announces intention to nominate Manny Maceda to board of directors

Key Takeaway: Stryker has announced the nomination of Manny Maceda to its board of directors for election at the 2025 Annual Meeting of Shareholders on May 8, 2025. Maceda, who has extensive experience in leading corporate transformations, currently serves as Chairman of Bain & Company. His nomination is expected to bring valuable strategic insights and enhance Stryker's governance as the company continues to grow and focus on delivering long-term shareholder value.

Market Sentiment Analysis

POSITIVE FACTORS

  • Manny Maceda brings over 30 years of leadership experience.
  • His previous roles include leading Bain & Company as CEO, enhancing his strategic acumen.
  • Stryker's leadership anticipates that Maceda will enhance board performance and long-term shareholder value.

Full Press Release Details

Portage, Michigan, March 26, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its board of directors has nominated Emmanuel “Manny” Maceda for election to the company’s board at the 2025 Annual Meeting of Shareholders, scheduled for May 8, 2025.
Manny brings more than 30 years of experience leading high-performing organizations and advising senior executives on large-scale corporate transformations. He currently serves as Chairman of Bain & Company, following his tenure as Worldwide Managing Partner and CEO from 2018 to 2024. In that role, he led Bain’s global strategy and operations across more than 50 offices, driving the firm’s transformation to strengthen digital capabilities, expand its focus on sustainability, and preserve its award-winning culture.
Since joining Bain in 1989, Maceda has held multiple senior leadership roles and advised CEOs across a wide range of industries on enterprise-wide initiatives spanning strategy, growth, cost management, and organizational effectiveness.
He holds a Master of Science in Management from the MIT Sloan School of Management where he serves on the advisory board, and a bachelor’s degree in chemical engineering, with High Honors, from the Illinois Institute of Technology.
“We look forward to the potential of adding Manny to our Board,” said Kevin Lobo, Chair and CEO, Stryker. “His strategic acumen, global leadership experience and track record in transformation will enhance the Board as we grow, evolve and create long-term value for shareholders.”
Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.
For investor inquiries:
Jason Beach, Vice President, Investor Relations at 269-385-2600 or jason.beach@stryker.com
For media inquiries:
Kim Montagnino, Vice President, Global Communications at 269-385-2600

Frequently Asked Questions

Who has been nominated to Stryker's board?

Emmanuel “Manny” Maceda has been nominated for election to Stryker's board.

When is the Stryker Annual Meeting scheduled?

The Annual Meeting of Shareholders is set for May 8, 2025.

What is Manny Maceda's current position?

Manny Maceda currently serves as Chairman of Bain & Company.

What degree does Manny Maceda hold?

He holds a Master of Science in Management from MIT Sloan.

What is Stryker known for?

Stryker is a leader in medical technologies enhancing healthcare outcomes.

Last updated: Mar 26, 2025